Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Cosmetics will soon be colour-coded

      Cosmetics will soon be colour-coded

      Ruby Khatun Khatun21 May 2018 10:15 AM IST
      New Delhi: On lines of packaged food products, cosmetics and toiletries like face wash, soaps, shampoos, and toothpastes will soon carry a brown/red...
      Glenmark announces oral presentation of New Data on GBR 830

      Glenmark announces oral presentation of New Data on GBR 830

      Ruby Khatun Khatun21 May 2018 10:00 AM IST
      Mumbai: Pharma Major, Glenmark Pharmaceuticals, a global pharmaceutical company, announced data from a Phase 2a, proof-of-concept study of GBR 830, an...
      DRCongo prepares for first Ebola vaccinations

      DRCongo prepares for first Ebola vaccinations

      Ruby Khatun Khatun21 May 2018 9:45 AM IST
      Kinshasa: The Democratic Republic of Congo is preparing to launch an Ebola vaccination programme Monday in a bid to stop the latest outbreak of the...
      Johnson and Johnson scraps Alzheimers trials on safety concerns

      Johnson and Johnson scraps Alzheimer's trials on safety concerns

      Ruby Khatun Khatun21 May 2018 9:30 AM IST
      Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer’s drug after observing safety issues, the latest drugmaker...
      Shortage of Drugs: 6 FOLD increase in Complaints with NPPA in 2017-18

      Shortage of Drugs: 6 FOLD increase in Complaints with NPPA in 2017-18

      Ruby Khatun Khatun20 May 2018 11:28 AM IST
      New Delhi: The complaints about the shortage or unavailability of drugs hat are filled with the National Pharmaceutical Pricing Authority (NPPA) have...
      Stempeutics partners with Cipla for its stem cell drug

      Stempeutics partners with Cipla for its stem cell drug

      Ruby Khatun Khatun20 May 2018 10:30 AM IST
      New Delhi: Biotech firm Stempeutics Research said it has inked an out-licensing deal with drug major Cipla for its stem cell therapy product...
      Strides Shasun Q4 net loss at Rs 4.40 crore, shares tank 23 percent

      Strides Shasun Q4 net loss at Rs 4.40 crore, shares tank 23 percent

      Ruby Khatun Khatun20 May 2018 10:15 AM IST
      New Delhi: Drug firm Strides Shasun reported a consolidated net loss of Rs 4.40 crore from the continuing operations.The company had posted a net...
      Suven gets product patents by Australia, Singapore

      Suven gets product patents by Australia, Singapore

      Ruby Khatun Khatun20 May 2018 10:00 AM IST
      New Delhi: Suven Life Sciences said it has been granted two product patents by Australia and one by Singapore corresponding to a new chemical entity...
      PE, VC investments in April touch USD 2.4 billion on large deals: EY

      PE, VC investments in April touch USD 2.4 billion on large deals: EY

      Ruby Khatun Khatun20 May 2018 9:45 AM IST
      New Delhi: Private equity and venture capital investments in April were up 23 percent at USD 2.4 billion, backed by large deals in sectors like...
      Regulators flag possible birth defect link to GSKs HIV drug

      Regulators flag possible birth defect link to GSK's HIV drug

      Ruby Khatun Khatun20 May 2018 9:30 AM IST
      LONDON: U.S. and European regulators said they were assessing evidence that GlaxoSmithKline’s (GSK) HIV drug dolutegravir might be linked to serious...
      40 US lawmakers seek exemption from additional tariffs on medical devices from China

      40 US lawmakers seek exemption from additional tariffs on medical devices from China

      Ruby Khatun Khatun20 May 2018 9:15 AM IST
      Washington: A bipartisan group of 40 lawmakers has urged US Trade Representative Robert Lighthizer to remove USD 3 billion worth of medical devices...
      Guidelines for Public procurement of Medical Devices released

      Guidelines for Public procurement of Medical Devices released

      Ruby Khatun Khatun19 May 2018 4:45 PM IST
      New Delhi: Through a recent notification, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, has released...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok